Metabolism-based drug discovery in zebrafish: an emerging strategy to uncover new anti-seizure therapies.
Ibhazehiebo K, Rho JM, Kurrasch DM — 2020
A novel metabolism-based phenotypic drug discovery platform in zebrafish uncovers HDACs 1 and 3 as a potential combined anti-seizure drug target.
Ibhazehiebo K, Gavrilovici C, de la Hoz CL, Ma SC, Rehak R, Kaushik G, Meza Santoscoy PL, Scott L, Nath N, Kim DY, Rho JM, Kurrasch DM — 24 January 2018